Table of Content

1 Vaccine for Influenza Market Overview
1.1 Product Overview and Scope of Vaccine for Influenza
1.2 Vaccine for Influenza Segment by Type
1.2.1 Global Vaccine for Influenza Market Value Comparison by Type (2024-2034)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Vaccine for Influenza Segment by Application
1.3.1 Global Vaccine for Influenza Market Value by Application: (2024-2034)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Vaccine for Influenza Market Size Estimates and Forecasts
1.4.1 Global Vaccine for Influenza Revenue 2018-2029
1.4.2 Global Vaccine for Influenza Sales 2018-2029
1.4.3 Global Vaccine for Influenza Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Vaccine for Influenza Market Competition by Manufacturers
2.1 Global Vaccine for Influenza Sales Market Share by Manufacturers (2018-2024)
2.2 Global Vaccine for Influenza Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Vaccine for Influenza Average Price by Manufacturers (2018-2024)
2.4 Global Vaccine for Influenza Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Vaccine for Influenza, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine for Influenza, Product Type & Application
2.7 Vaccine for Influenza Market Competitive Situation and Trends
2.7.1 Vaccine for Influenza Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaccine for Influenza Players Market Share by Revenue
2.7.3 Global Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccine for Influenza Retrospective Market Scenario by Region
3.1 Global Vaccine for Influenza Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Vaccine for Influenza Global Vaccine for Influenza Sales by Region: 2018-2029
3.2.1 Global Vaccine for Influenza Sales by Region: 2018-2024
3.2.2 Global Vaccine for Influenza Sales by Region: 2024-2029
3.3 Global Vaccine for Influenza Global Vaccine for Influenza Revenue by Region: 2018-2029
3.3.1 Global Vaccine for Influenza Revenue by Region: 2018-2024
3.3.2 Global Vaccine for Influenza Revenue by Region: 2024-2029
3.4 North America Vaccine for Influenza Market Facts & Figures by Country
3.4.1 North America Vaccine for Influenza Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Vaccine for Influenza Sales by Country (2018-2029)
3.4.3 North America Vaccine for Influenza Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaccine for Influenza Market Facts & Figures by Country
3.5.1 Europe Vaccine for Influenza Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Vaccine for Influenza Sales by Country (2018-2029)
3.5.3 Europe Vaccine for Influenza Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine for Influenza Market Facts & Figures by Country
3.6.1 Asia Pacific Vaccine for Influenza Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Vaccine for Influenza Sales by Country (2018-2029)
3.6.3 Asia Pacific Vaccine for Influenza Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaccine for Influenza Market Facts & Figures by Country
3.7.1 Latin America Vaccine for Influenza Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Vaccine for Influenza Sales by Country (2018-2029)
3.7.3 Latin America Vaccine for Influenza Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine for Influenza Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine for Influenza Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Vaccine for Influenza Sales by Country (2018-2029)
3.8.3 Middle East and Africa Vaccine for Influenza Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccine for Influenza Sales by Type (2018-2029)
4.1.1 Global Vaccine for Influenza Sales by Type (2018-2024)
4.1.2 Global Vaccine for Influenza Sales by Type (2024-2029)
4.1.3 Global Vaccine for Influenza Sales Market Share by Type (2018-2029)
4.2 Global Vaccine for Influenza Revenue by Type (2018-2029)
4.2.1 Global Vaccine for Influenza Revenue by Type (2018-2024)
4.2.2 Global Vaccine for Influenza Revenue by Type (2024-2029)
4.2.3 Global Vaccine for Influenza Revenue Market Share by Type (2018-2029)
4.3 Global Vaccine for Influenza Price by Type (2018-2029)
5 Segment by Application
5.1 Global Vaccine for Influenza Sales by Application (2018-2029)
5.1.1 Global Vaccine for Influenza Sales by Application (2018-2024)
5.1.2 Global Vaccine for Influenza Sales by Application (2024-2029)
5.1.3 Global Vaccine for Influenza Sales Market Share by Application (2018-2029)
5.2 Global Vaccine for Influenza Revenue by Application (2018-2029)
5.2.1 Global Vaccine for Influenza Revenue by Application (2018-2024)
5.2.2 Global Vaccine for Influenza Revenue by Application (2024-2029)
5.2.3 Global Vaccine for Influenza Revenue Market Share by Application (2018-2029)
5.3 Global Vaccine for Influenza Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Sanofi Vaccine for Influenza Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
6.2.4 CSL Vaccine for Influenza Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
6.3.4 GSK Vaccine for Influenza Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Viatris Vaccine for Influenza Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
6.5.4 AstraZeneca Vaccine for Influenza Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Hualan Bio Vaccine for Influenza Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Changchun Institute of Biological Vaccine for Influenza Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Sinovac Vaccine for Influenza Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Corporation Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
6.9.4 BCHT Vaccine for Influenza Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Corporation Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Jiangsu GDK Vaccine for Influenza Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Corporation Information
6.11.2 KM Biologics Vaccine for Influenza Description and Business Overview
6.11.3 KM Biologics Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
6.11.4 KM Biologics Vaccine for Influenza Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine for Influenza Industry Chain Analysis
7.2 Vaccine for Influenza Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine for Influenza Production Mode & Process
7.4 Vaccine for Influenza Sales and Marketing
7.4.1 Vaccine for Influenza Sales Channels
7.4.2 Vaccine for Influenza Distributors
7.5 Vaccine for Influenza Customers
8 Vaccine for Influenza Market Dynamics
8.1 Vaccine for Influenza Industry Trends
8.2 Vaccine for Influenza Market Drivers
8.3 Vaccine for Influenza Market Challenges
8.4 Vaccine for Influenza Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Vaccine for Influenza Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Vaccine for Influenza Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Vaccine for Influenza Market Competitive Situation by Manufacturers in 2022
Table 4. Global Vaccine for Influenza Sales (M Units) of Key Manufacturers (2018-2024)
Table 5. Global Vaccine for Influenza Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Vaccine for Influenza Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Vaccine for Influenza Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Vaccine for Influenza Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Vaccine for Influenza, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Vaccine for Influenza, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaccine for Influenza, Product Type & Application
Table 12. Global Key Manufacturers of Vaccine for Influenza, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccine for Influenza by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Influenza as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccine for Influenza Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Vaccine for Influenza Sales by Region (2018-2024) & (M Units)
Table 18. Global Vaccine for Influenza Sales Market Share by Region (2018-2024)
Table 19. Global Vaccine for Influenza Sales by Region (2024-2029) & (M Units)
Table 20. Global Vaccine for Influenza Sales Market Share by Region (2024-2029)
Table 21. Global Vaccine for Influenza Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Vaccine for Influenza Revenue Market Share by Region (2018-2024)
Table 23. Global Vaccine for Influenza Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Vaccine for Influenza Revenue Market Share by Region (2024-2029)
Table 25. North America Vaccine for Influenza Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Vaccine for Influenza Sales by Country (2018-2024) & (M Units)
Table 27. North America Vaccine for Influenza Sales by Country (2024-2029) & (M Units)
Table 28. North America Vaccine for Influenza Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Vaccine for Influenza Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Vaccine for Influenza Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Vaccine for Influenza Sales by Country (2018-2024) & (M Units)
Table 32. Europe Vaccine for Influenza Sales by Country (2024-2029) & (M Units)
Table 33. Europe Vaccine for Influenza Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Vaccine for Influenza Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Vaccine for Influenza Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Vaccine for Influenza Sales by Region (2018-2024) & (M Units)
Table 37. Asia Pacific Vaccine for Influenza Sales by Region (2024-2029) & (M Units)
Table 38. Asia Pacific Vaccine for Influenza Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Vaccine for Influenza Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Vaccine for Influenza Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Vaccine for Influenza Sales by Country (2018-2024) & (M Units)
Table 42. Latin America Vaccine for Influenza Sales by Country (2024-2029) & (M Units)
Table 43. Latin America Vaccine for Influenza Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Vaccine for Influenza Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Vaccine for Influenza Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Vaccine for Influenza Sales by Country (2018-2024) & (M Units)
Table 47. Middle East & Africa Vaccine for Influenza Sales by Country (2024-2029) & (M Units)
Table 48. Middle East & Africa Vaccine for Influenza Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Vaccine for Influenza Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Vaccine for Influenza Sales (M Units) by Type (2018-2024)
Table 51. Global Vaccine for Influenza Sales (M Units) by Type (2024-2029)
Table 52. Global Vaccine for Influenza Sales Market Share by Type (2018-2024)
Table 53. Global Vaccine for Influenza Sales Market Share by Type (2024-2029)
Table 54. Global Vaccine for Influenza Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Vaccine for Influenza Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Vaccine for Influenza Revenue Market Share by Type (2018-2024)
Table 57. Global Vaccine for Influenza Revenue Market Share by Type (2024-2029)
Table 58. Global Vaccine for Influenza Price (US$/Unit) by Type (2018-2024)
Table 59. Global Vaccine for Influenza Price (US$/Unit) by Type (2024-2029)
Table 60. Global Vaccine for Influenza Sales (M Units) by Application (2018-2024)
Table 61. Global Vaccine for Influenza Sales (M Units) by Application (2024-2029)
Table 62. Global Vaccine for Influenza Sales Market Share by Application (2018-2024)
Table 63. Global Vaccine for Influenza Sales Market Share by Application (2024-2029)
Table 64. Global Vaccine for Influenza Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Vaccine for Influenza Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Vaccine for Influenza Revenue Market Share by Application (2018-2024)
Table 67. Global Vaccine for Influenza Revenue Market Share by Application (2024-2029)
Table 68. Global Vaccine for Influenza Price (US$/Unit) by Application (2018-2024)
Table 69. Global Vaccine for Influenza Price (US$/Unit) by Application (2024-2029)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Sanofi Vaccine for Influenza Product
Table 74. Sanofi Recent Developments/Updates
Table 75. CSL Corporation Information
Table 76. CSL Description and Business Overview
Table 77. CSL Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. CSL Vaccine for Influenza Product
Table 79. CSL Recent Developments/Updates
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. GSK Vaccine for Influenza Product
Table 84. GSK Recent Developments/Updates
Table 85. Viatris Corporation Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Viatris Vaccine for Influenza Product
Table 89. Viatris Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. AstraZeneca Vaccine for Influenza Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Hualan Bio Corporation Information
Table 96. Hualan Bio Description and Business Overview
Table 97. Hualan Bio Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Hualan Bio Vaccine for Influenza Product
Table 99. Hualan Bio Recent Developments/Updates
Table 100. Changchun Institute of Biological Corporation Information
Table 101. Changchun Institute of Biological Description and Business Overview
Table 102. Changchun Institute of Biological Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Changchun Institute of Biological Vaccine for Influenza Product
Table 104. Changchun Institute of Biological Recent Developments/Updates
Table 105. Sinovac Corporation Information
Table 106. Sinovac Description and Business Overview
Table 107. Sinovac Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Sinovac Vaccine for Influenza Product
Table 109. Sinovac Recent Developments/Updates
Table 110. BCHT Corporation Information
Table 111. BCHT Description and Business Overview
Table 112. BCHT Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. BCHT Vaccine for Influenza Product
Table 114. BCHT Recent Developments/Updates
Table 115. Jiangsu GDK Corporation Information
Table 116. Jiangsu GDK Description and Business Overview
Table 117. Jiangsu GDK Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Jiangsu GDK Vaccine for Influenza Product
Table 119. Jiangsu GDK Recent Developments/Updates
Table 120. KM Biologics Corporation Information
Table 121. KM Biologics Description and Business Overview
Table 122. KM Biologics Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. KM Biologics Vaccine for Influenza Product
Table 124. KM Biologics Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Vaccine for Influenza Distributors List
Table 128. Vaccine for Influenza Customers List
Table 129. Vaccine for Influenza Market Trends
Table 130. Vaccine for Influenza Market Drivers
Table 131. Vaccine for Influenza Market Challenges
Table 132. Vaccine for Influenza Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vaccine for Influenza
Figure 2. Global Vaccine for Influenza Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Vaccine for Influenza Market Share by Type in 2022 & 2029
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Vaccine for Influenza Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Vaccine for Influenza Market Share by Application in 2022 & 2029
Figure 8. 6 Months to 3 Years
Figure 9. > 3 Years
Figure 10. Global Vaccine for Influenza Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Vaccine for Influenza Market Size (2018-2029) & (US$ Million)
Figure 12. Global Vaccine for Influenza Sales (2018-2029) & (M Units)
Figure 13. Global Vaccine for Influenza Average Price (US$/Unit) & (2018-2029)
Figure 14. Vaccine for Influenza Report Years Considered
Figure 15. Vaccine for Influenza Sales Share by Manufacturers in 2022
Figure 16. Global Vaccine for Influenza Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Vaccine for Influenza Players: Market Share by Revenue in 2022
Figure 18. Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Vaccine for Influenza Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Vaccine for Influenza Sales Market Share by Country (2018-2029)
Figure 21. North America Vaccine for Influenza Revenue Market Share by Country (2018-2029)
Figure 22. United States Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Vaccine for Influenza Sales Market Share by Country (2018-2029)
Figure 25. Europe Vaccine for Influenza Revenue Market Share by Country (2018-2029)
Figure 26. Germany Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Vaccine for Influenza Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Vaccine for Influenza Revenue Market Share by Region (2018-2029)
Figure 33. China Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Latin America Vaccine for Influenza Sales Market Share by Country (2018-2029)
Figure 41. Latin America Vaccine for Influenza Revenue Market Share by Country (2018-2029)
Figure 42. Mexico Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Brazil Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Argentina Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Vaccine for Influenza Sales Market Share by Country (2018-2029)
Figure 46. Middle East & Africa Vaccine for Influenza Revenue Market Share by Country (2018-2029)
Figure 47. Turkey Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. UAE Vaccine for Influenza Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Global Sales Market Share of Vaccine for Influenza by Type (2018-2029)
Figure 51. Global Revenue Market Share of Vaccine for Influenza by Type (2018-2029)
Figure 52. Global Vaccine for Influenza Price (US$/Unit) by Type (2018-2029)
Figure 53. Global Sales Market Share of Vaccine for Influenza by Application (2018-2029)
Figure 54. Global Revenue Market Share of Vaccine for Influenza by Application (2018-2029)
Figure 55. Global Vaccine for Influenza Price (US$/Unit) by Application (2018-2029)
Figure 56. Vaccine for Influenza Value Chain
Figure 57. Vaccine for Influenza Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed